Follow-The-Filings

OSTX OS Therapies

OS Therapies earnings company data as of 7:18 PM ET 8/21

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS -0.20
Rev

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,9.01
10-Q QUARTERLY REPORT
8-K 1.01,2.03,3.02,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,2.03,3.02,9.01
8-K 1.02
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K/A 9.01
8-K 1.01,2.03,3.02,5.02,8.01,9.01
10-Q QUARTERLY REPORT
8-K 7.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,8.01,9.01
10-K ANNUAL REPORT
424B7 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
8-K 1.01,2.03,3.02,9.01
8-K 8.01
8-K 1.01,3.02,8.01,9.01
10-Q QUARTERLY REPORT
8-K 5.02,5.07,9.01
DEFA14A CURRENT REPORT

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4/A Period Oct 21, 2025
4 Period Jan 22, 2026 · 4 forms

12 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice